GALLAHUE KIERAN 4

What Happened
Kieran Gallahue, a director of Edwards Lifesciences (EW), was granted two restricted stock awards on May 8, 2026: 3,251 RSUs and 1,064 RSUs, for a total of 4,315 RSUs. The grants are recorded at $0.00 in the Form 4 because these are compensatory awards (not open‑market purchases or sales) that will convert to common shares only upon vesting.

Key Details

• Transaction date: 2026-05-08 (reported on Form 4 filed 2026-05-08). Transaction code: A = Award/Grant.
• Shares granted: 3,251 RSUs and 1,064 RSUs (total 4,315 RSUs). Price per share: $0.00 as listed (compensatory grant).
• Vesting: Each award vests 100% on the earlier of one year from grant or the issuer’s next annual meeting (per footnotes F1 and F2).
• Shares owned after transaction: Not disclosed on this Form 4 (filing notes it reflects changes in beneficial ownership only).
• Timeliness: No late‑filing indicator; report appears filed the same day as the grants.

Context
These awards are standard non‑employee director compensation and represent future shares contingent on vesting. Because they are not purchases or sales, they are a routine form of pay rather than a direct market sentiment signal.